FindTrial
Sign In

A Single-Blinded, Randomized, Split-Face Study of Efficacy and Safety Using Fractional Picosecond 1064 nm Nd:YAG Compared to Fractional 1550 nm Ytterbium/Erbium Fiber Laser in Facial Rejuvenation and Treatment of Dilated Pores in Asian

A Single-Blinded, Randomized, Split-Face Study of Efficacy and Safety Using Fractional Picosecond 1064 nm Nd:YAG Compared to Fractional 1550 nm Ytterbium/Erbium Fiber Laser in Facial Rejuvenation and Treatment of Dilated Pores in Asian

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171130003
Enrollment
Unknown
Registered
2017-11-30
Start date
2017-10-04
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dilated pores&#44

Interventions

Fractional Picosecond 1064 nm Nd:YAG by PicoWay®&#44
Syneron Candela Corp&#44
Wayland&#44
MA Parameters : ,Fractional 1550 nm Ytterbium/Erbium Fiber Laser by Finescan(â„¢)
TNC Medditron Co.&#44
Ltd.&#44
Thailand Parameters :
Experimental Device,Active Comparator Device
Fractional Picosecond 1064 nm Nd:YAG,Fractional 1550 nm Ytterbium/Erbium Fiber Laser

Sponsors

Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol U
Lead Sponsor
Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age between 35 – 50 year-old 2. No history of photo allergy 3. Compatible with follow-up schedule 4. Informed consent

Exclusion criteria

Exclusion criteria: 1. Pregnancy or Giving lactationตั้งครรภ์ หรือให้นมบุตร 2. Previously treated with rejuvenation energy-based devices within 3 months 3. Underlying diseases of autoimmune diseases 4. Wounds or severe cystic acne on the face 5. Presence of pre-existing skin diseases on the face 6. Patients with severe underlying diseases 7. Withdraw

Design outcomes

Primary

MeasureTime frame
Improvement score in wrinkles, pore size and pigmentary lesions Week 12, Week 16, Week 20 Visual analogue scores, evaluated by blinded dermatologists and patients,Pores volume Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Visioscan,Transepidermal water loss Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 DermaLab® Combo,Pigmentary melanin index Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Chromameter CR-200 Panasonic—

Secondary

MeasureTime frame
Adverse effects Week 0, Week 4, Week 8, Week 12, Week 16, Week 20 Evaluated from patients and attending dermatologists,Patient satisfaction Week 12, Week 16, Week 20 Patients satisfaction rating score—

Countries

Thailand

Contacts

Public ContactSarawin Harnchoowong

Division of Dermatology, Faculty of Medicine Ramathibodi Hospital

hsarawin@gmail.com6622011211

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026